Seguir
Martin Köbel
Martin Köbel
Associate Professor, University of Calgary
Dirección de correo verificada de ucalgary.ca
Título
Citado por
Citado por
Año
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies
M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ...
PLoS medicine 5 (12), e232, 2008
9622008
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ...
New England Journal of Medicine 360 (26), 2719-2729, 2009
8572009
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
RGW Verhaak, P Tamayo, JY Yang, D Hubbard, H Zhang, CJ Creighton, ...
The Journal of clinical investigation 123 (1), 2012
6502012
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ...
The lancet oncology 14 (9), 853-862, 2013
4652013
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors
K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao, CB Gilks, PH Watson, ...
PloS one 4 (7), e6412, 2009
4632009
Invasive epithelial ovarian cancer survival by histotype and disease stage
LC Peres, KL Cushing-Haugen, M Köbel, HR Harris, A Berchuck, ...
JNCI: Journal of the National Cancer Institute 111 (1), 60-68, 2019
4492019
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
4122017
Differences in tumor type in low-stage versus high-stage ovarian carcinomas
M Köbel, SE Kalloger, DG Huntsman, JL Santos, KD Swenerton, ...
International Journal of Gynecological Pathology 29 (3), 203-211, 2010
4112010
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
M Köbel, AM Piskorz, S Lee, S Lui, C LePage, F Marass, N Rosenfeld, ...
The Journal of Pathology: Clinical Research 2 (4), 247-258, 2016
3582016
Expression of cyclooxygenase 2 in human malignant melanoma
C Denkert, M Köbel, S Berger, A Siegert, A Leclere, U Trefzer, ...
Cancer research 61 (1), 303-308, 2001
3482001
Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma
C Denkert, KJ Winzer, BM Müller, W Weichert, S Pest, M Köbel, ...
Cancer 97 (12), 2978-2987, 2003
3362003
Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility
M Köbel, BM Ronnett, N Singh, RA Soslow, CB Gilks, WG McCluggage
International journal of gynecological pathology 38, S123-S131, 2019
3192019
Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010
MS Anglesio, MS Carey, M Köbel, H MacKay, DG Huntsman
Gynecologic oncology 121 (2), 407-415, 2011
3032011
Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma
C Denkert, M Köbel, S Pest, I Koch, S Berger, M Schwabe, A Siegert, ...
The American journal of pathology 160 (3), 893-903, 2002
2912002
Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
EL Goode, MS Block, KR Kalli, RA Vierkant, W Chen, ZC Fogarty, ...
JAMA oncology 3 (12), e173290-e173290, 2017
2842017
The fallopian tube: primary site of most pelvic high-grade serous carcinomas
S Salvador, B Gilks, M Köbel, D Huntsman, B Rosen, D Miller
International Journal of Gynecologic Cancer 19 (1), 2009
2782009
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
CB Gilks, DN Ionescu, SE Kalloger, M Köbel, J Irving, B Clarke, J Santos, ...
Human pathology 39 (8), 1239-1251, 2008
2712008
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
W Weichert, C Denkert, M Schmidt, V Gekeler, G Wolf, M Köbel, M Dietel, ...
British journal of cancer 90 (4), 815-821, 2004
2542004
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary
M Köbel, SE Kalloger, J Carrick, D Huntsman, H Asad, E Oliva, ...
The American journal of surgical pathology 33 (1), 14-21, 2009
2512009
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
YR Hussein, B Weigelt, DA Levine, JK Schoolmeester, LN Dao, BL Balzer, ...
Modern Pathology 28 (4), 505-514, 2015
2382015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20